AI assistant
Sending…
AGENUS INC — Director's Dealing 2010
Jan 28, 2010
34023_dirs_2010-01-28_811d21f7-25cb-413a-ad37-70cc8f1db361.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-01-26
Reporting Person: Sharp Shalini (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-01-26 | Stock Option, right to buy | $0.75 | A | 125000 | Acquired | 2020-01-26 | Common Stock (125000) | Direct |
| 2010-01-26 | Restricted Stock | $ | A | 45000 | Acquired | Common Stock (45000) | Direct |
Footnotes
F1: Options granted in accordance with the Antigenics Inc. 2009 Equity Incentive Plan and vest quarterly over three years beginning April 26, 2010.
F2: Restricted Stock granted in accordance with the Antigenics Inc. 2009 Equity Incentive Plan and vests quarterly over three years beginning April 26, 2010.
More from AGENUS INC
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 9
Director's Dealing
2026
Jan 26
Major Shareholding Notification
2026
Jan 23